CAV1 and pulmonary fibrosis: Collectively, these results demonstrate that electroporation-mediated gene transfer of Cav-1 can protect against subsequent bleomycin-induced pulmonary fibrosis and abrogate pulmonary inflammatory response to bleomycin injury.